United Therapeutics

+$2.04 (+1.11%) Today

$0.00 (0.00%) As of 11:11 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell UTHR and other ETFs, options, and stocks.

About UTHR

United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. The firm markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma.

CEO

Martine A. Rothblatt

Employees

950

Headquarters

Silver Spring, Maryland

Founded

1996

UTHR Key Statistics

Market Cap

8.37B

Price-Earnings Ratio

17.92

Dividend Yield

—

Average Volume

376.43K

High Today

$187.00

Low Today

$182.38

Open Price

$182.60

Volume

279.66K

52 Week High

$216.90

52 Week Low

$115.53

UTHR News

BenzingaOct 18

FDA Declines MannKind - United Therapeutics' Formulated Treprostinil For Lung Disease

Motley Fool Shares of MannKind (NASDAQ: MNKD), a company working to develop inhaled therapeutics, were down 18% as of 11:59 a.m. EDT on Monday after an inspect

MarketWatchOct 18

United Therapeutics New Drug Application Declined Pending Inspection Issue

By Matt Grossman United Therapeutics Corp.'s Tyvaso drug application wasn't approved by the Food and Drug Administration, but the issue cited by the agency can

Analyst Ratings

90%

of 10 ratings

Buy

90%

Hold

Sell

10%

UTHR Earnings

$0.00

$1.36

$2.73

$4.09

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Estimated

— per share

Actual

Expected Nov 3, Pre-Market